Literature DB >> 10052736

Medullary thyroid carcinoma with multiple hepatic metastases: treatment with transcatheter arterial embolization and percutaneous ethanol injection.

T Isozaki1, T Kiba, K Numata, S Saito, T Shimamura, T Kitamura, K Morita, K Tanaka, H Sekihara.   

Abstract

A 54-year-old man with medullary thyroid carcinoma in the thyroid gland was unable to undergo total thyroidectomy because the tumor had invaded the mediastinum. Radiation therapy and chemotherapy were given. Seven years later, intractable diarrhea and abdominal pain appeared, and computed tomography demonstrated hypervascular tumors in the thyroid gland and in the liver. The tumors were successfully treated with percutaneous ethanol injection to a lesion in the thyroid gland and transcatheter arterial embolization followed by percutaneous ethanol injection to tumors in the liver. Transcatheter arterial embolization and percutaneous ethanol injection may be valuable in treating medullary thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10052736     DOI: 10.2169/internalmedicine.38.17

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  11 in total

Review 1.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

2.  Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.

Authors:  Renata Jaskula-Sztul; Wenjin Xu; Guojun Chen; April Harrison; Ajitha Dammalapati; Renu Nair; Yiqiang Cheng; Shaoqin Gong; Herbert Chen
Journal:  Biomaterials       Date:  2016-03-08       Impact factor: 12.479

3.  Neuroendocrine Tumor-Targeted Upconversion Nanoparticle-Based Micelles for Simultaneous NIR-Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging.

Authors:  Guojun Chen; Renata Jaskula-Sztul; Corinne R Esquibel; Irene Lou; Qifeng Zheng; Ajitha Dammalapati; April Harrison; Kevin W Eliceiri; Weiping Tang; Herbert Chen; Shaoqin Gong
Journal:  Adv Funct Mater       Date:  2017-01-17       Impact factor: 18.808

Review 4.  A primer on the genetics of medullary thyroid cancer.

Authors:  V Larouche; A Akirov; C M Thomas; M K Krzyzanowska; S Ezzat
Journal:  Curr Oncol       Date:  2019-12-01       Impact factor: 3.677

5.  RET mutations in a large indian family with medullary thyroid carcinoma.

Authors:  D M Mahesh; Arun G Nehru; M S Seshadri; Nihal Thomas; Aravindan Nair; Rekha Pai; Simon Rajaratnam
Journal:  Indian J Endocrinol Metab       Date:  2014-07

Review 6.  Ethanol Ablation of the Thyroid Nodules: 2018 Consensus Statement by the Korean Society of Thyroid Radiology.

Authors:  Soo Yeon Hahn; Jung Hee Shin; Dong Gyu Na; Eun Joo Ha; Hye Shin Ahn; Hyun Kyung Lim; Jeong Hyun Lee; Jeong Seon Park; Ji Hoon Kim; Jin Yong Sung; Joon Hyung Lee; Jung Hwan Baek; Jung Hyun Yoon; Jung Suk Sim; Kwang Hwi Lee; Seon Mi Baek; So Lyung Jung; Yeo Koon Kim; Yoon Jung Choi
Journal:  Korean J Radiol       Date:  2019-04       Impact factor: 3.500

7.  Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment.

Authors:  Yingnan Si; JiaShiung Guan; Yuanxin Xu; Kai Chen; Seulhee Kim; Lufang Zhou; Renata Jaskula-Sztul; X Margaret Liu
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

8.  Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy.

Authors:  Yingnan Si; Seulhee Kim; Jianfa Ou; Yun Lu; Patrick Ernst; Kai Chen; Jason Whitt; Angela M Carter; James M Markert; James A Bibb; Herbert Chen; Lufang Zhou; Renata Jaskula-Sztul; Xiaoguang Margaret Liu
Journal:  Cancer Gene Ther       Date:  2020-07-20       Impact factor: 5.987

9.  Acute liver failure secondary to metastatic medullary thyroid cancer.

Authors:  Emmanuel C Gorospe; Jemilat Badamas
Journal:  Case Reports Hepatol       Date:  2012-01-15

10.  Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.

Authors:  Samuel Jang; Haining Jin; Madhuchhanda Roy; Alice L Ma; Shaoqin Gong; Renata Jaskula-Sztul; Herbert Chen
Journal:  Cancer Med       Date:  2017-08-04       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.